KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Alnylam Pharmaceuticals (ALNY) over the last 15 years, with Dec 2024 value amounting to $117.0 million.

  • Alnylam Pharmaceuticals' Prepaid Assets rose 29.37% to $188.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.0 million, marking a year-over-year increase of 29.37%. This contributed to the annual value of $117.0 million for FY2024, which is 7.45% down from last year.
  • Latest data reveals that Alnylam Pharmaceuticals reported Prepaid Assets of $117.0 million as of FY2024, which was down 7.45% from $126.4 million recorded in FY2023.
  • In the past 5 years, Alnylam Pharmaceuticals' Prepaid Assets registered a high of $132.9 million during FY2022, and its lowest value of $62.8 million during FY2020.
  • Moreover, its 3-year median value for Prepaid Assets was $126.4 million (2023), whereas its average is $125.4 million.
  • Per our database at Business Quant, Alnylam Pharmaceuticals' Prepaid Assets decreased by 21.88% in 2020 and then soared by 50.91% in 2022.
  • Yearly analysis of 5 years shows Alnylam Pharmaceuticals' Prepaid Assets stood at $62.8 million in 2020, then spiked by 40.33% to $88.1 million in 2021, then spiked by 50.91% to $132.9 million in 2022, then fell by 4.92% to $126.4 million in 2023, then decreased by 7.45% to $117.0 million in 2024.